Latest AIM Breakfast
AIM BREAKFAST – 14 November 2018
Set Menu AIM:
Total number of AIM Companies (Incl Susp): 922
Total number of AIM Companies trading: 851*
* As at 09 November 2018
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
Set Menu ISDX Growth:
Total number of ISDX Growth Market Companies (Incl Susp): 88*
Total number of ISDX Growth Market Companies trading: 86*
* As at 09 November 2018
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
Main Market (Premium)
AJ Bell—one of the largest investment platforms in the UK—Expects to publish prospectus end Nov. FYSep18—revenues up 19% to £89.7 million, profit before tax up 31% to £28.4 million.
Nova Ljuublianska banka—financial and banking institution based in Slovenia with a network of 349 branches, dual listing process in Ljubliana with GDRs in London. For HYJun18 and for FY17 the Group recorded a net profit equal to EUR 104.8 million and EUR 225.1 million, respectively. 50% plus sell down. Estimated mkt cap €1bn to €1.3bn. Due 14 Nov
Sirius Aircraft Leasing Fund targeting a raise of US$250m – objective is to provide investors with an attractive level of regular income and capital returns through investing primarily in used, single-aisle aircraft. Due early Nov
Main Market (Specialist Funds)
The Global Sustainability Trust -aiming for attractive risk-adjusted returns by investing primarily in private market investments that are expected to have a positive environmental and social impact raising c.£200m. Due end Nov.
Kropz, an emerging plant nutrient producer with an advanced stage phosphate mining project in South Africa, a phosphate project in the Republic of Congo and exploration assets in Ghana, is looking to join AIM. Offer TBC, expected late Nov
Titon holdings—international manufacturer and supplier of ventilation systems and window and door hardware. No capital raise. Due 10 Dec. Mkt cap c.£22m.
Greenfields Petroleum (TSX-V:GNF) production focused company with operated assets in Azerbaijan seeking AIM dual listing including $60m private placement. Mkt cap $12.6m CAD
Finncap—proposed acquisition of M&A adviser Cavendish Corporate Finance and AIM admission. Offer TBA
Crossword Cybersecurity PLC* (NEX:CCS)—the technology commercialisation company focusing exclusively on the cyber security sector is investigating the possibility of AIM admission. The Company is proposing to raise up to £2.25 million before the end of December, conditional on Admission.
Conroy Gold & Natural resources (CGNR.L) 11.25p £2.72m
FYMay18 results. €745k loss vs €432k. £1m raised in the year via a placing plus €167 from director warrant exercises.
Excellent drilling results at Clontibret including the discovery of an extensive gold zone and additional major targets discovered within the Clontibret area. Updated JORC compliant mineral resource of 517,000 ounces.
Updated estimated Exploration Target* of 8.8Moz gold for the combined Clontibret, Clay Lake and Glenish areas.
Further exploration potential on other licences along the Orlock Bridge Fault.
Discovery of a new area of bedrock gold mineralisation halfway between the Clontibret gold deposit and the Corcaskea gold target in Ireland.
Cambridge Cognition (COG.L) 114p £22.4m
The specialist in neuroscience technology to assess brain health, today announced it has won a significant new clinical trial contract, which is the largest in a series of recently signed electronic clinical outcomes assessment (eCOA) trials.
The contract is worth over $0.75m with a new client for the Company, a specialty pharmaceutical developer, over a one-year period. It is the largest of a number of eCOA contracts won since Cambridge Cognition decided to increase the value of its software service by expanding the capabilities of its CANTAB Connect platform. The technology now enables the assessment of multiple outcomes, in addition to cognitive measures, on a single platform.
FY2018E revs of £6.9m and EBITDA of -£0.4m
AB Dynamics (ABDP.L) 1,425p £271m
FYAug18 results from the designer, manufacturer and supplier of advanced testing systems and measurement products to the global automotive industry.
Revenue increased 51% to £37.05m (FY17: £24.57m)
Reported PBT increased 78% to £7.95m (FY17: £4.47m)
PBT increased 45% to £8.61m (FY17: £5.94m)
Diluted EPS increased 70% to 35.03p (FY17: 20.56p)
Proposed final dividend increased 10% to 2.20p per ordinary share (FY17: 2.00p)
Strong balance sheet with net cash of £15.94m as at 31 Aug 2018
Very strong outlook statement although hints at increasing cost base to accommodate growth which may constrain margins.
Falanx (FLX.L) 3.12p £7.99m
HYSep18 results from the cybersecurity and intelligence provider .
Group revenues increased 51% to £2.2m (2017: £1.4m) and gross margin increased to 36% (2017: 27%). 198% increase in Cyber division revenues to £1.4m (2017: £0.47m) Underlying EBITDA £0.71m loss (2017: £0.85m loss),
Recurring revenues remain strong and grew by 41% to £1.2m
Cash of £69k.
“The SolarWinds opportunity is transformational for Falanx both in terms of customer capture and potential financial returns. Over the next few months, there will be a necessary expansion in the deployment of our resources to meet the expected increase in activity. Whilst revenues for the first half, although well ahead of the same period last year, have been slightly lower than our original internal expectations”.
We could see no forecasts.
Lighthouse Group (LGT.L) 27.3p £33.8m
“The national financial advisory group, is pleased to announce that it has entered into a strategic relationship with Tavistock Investments plc.
Lighthouse currently advises clients with assets in excess of £5bn and on new investment and pension flows of circa £1bn p.a. The Strategic Agreement will enable Lighthouse and its advisers and clients to access Tavistock’s investment solutions, including its capital protection fund products that are principally invested in iShares by BlackRock and guaranteed by Morgan Stanley, all managed to the client’s agreed risk profile.”
Marshall Motor Holdings (MMH.L) 156p £114m
“One of the UK’s leading automotive retail groups, issues the following trading update in response to better than anticipated trading during Oct 2018 and a more positive outlook for the remainder of the current financial year.
As previously announced on 11 Oct 2018, the introduction of the new Worldwide Harmonised Light Vehicle Test Procedure had a significant impact on the UK new vehicle market during Sept 2018 which was expected to continue for the remainder of the year. Whilst the resultant new car supply imbalance is continuing, growth in our used car volumes and margins given supply constraints in the new car market, combined with further revenue growth achieved in aftersales, has given us more confidence over the expected outcome for the year. As a result, the Board now expects continuing underlying profit before tax for the year ending 31 Dec 2018 to be ahead of the Group’s record results reported last year.”
FY2018E revs of £2,191m and EBITDA of £39.8m
Tekcapital (TEK.L) 6.25p £3.51m
“The UK intellectual property (IP) investment group focused on creating marketplace value from university technology, is pleased to announce that wholly owned portfolio company Lucyd ltd has launched an Affiliate and Reseller Program.
Lucyd Pte Ltd, the developer of an eShop for innovative spectacles, has launched a global affiliate and reseller program using the Leaddyno and Shareasale affiliate platforms. Lucyd has also introduced a reseller Intro Kit to provide initial stock and marketing materials for Lucyd products. As of today, seventy affiliates have already signed-up.
Interested parties are encouraged to sign up at Lucyd.leaddyno.com and contact info@Lucyd.co for assistance. Lucyd will regularly update the platforms with new collateral content, as well as publish a weekly affiliate newsletter.”
Craven House (CRV.L) 3.30p £6.44m
“Craven House announced its participation in a Public Offering for shares of LM Funding America, Inc.. The Company has acquired 640,000 common shares at a price of $2.40 per share for a total consideration of c.$1.5m. The Company’s position represents 31.5% of the common shares in LMFA.
In the year to 31 Dec 2017, LM Funding America made a loss before income tax of $5.2m and had total assets of $2m.”
LM Funding America, Inc., together with its subsidiaries, is a technology-based specialty finance company that provides funding to non-profit community associations primarily located in the state of Florida.
Maestrano (MNO.L) 9.12p £7m
The open cloud business integration platform with cross-app data synchronization, announces it has now successfully gone live with a platform for a major US based banking customer.
This Maestrano platform is used by Enterprises to assemble and serve integrated suites of Cloud applications with value-adding data analytics to drive engagement with their small and medium sized customers. Maestrano has been working with the US Bank for almost a year developing new digital services using the Maestrano platform which allow increased functionality for SMB users.
Science in Sport (SIS.L) 61.5p £47.4m
The endurance sports nutrition company that develops, manufactures and markets sports nutrition products for elite athletes and sports enthusiasts, announced the proposed acquisition of PhD Nutrition Ltd (“PhD”), a premium, innovation-led protein brand for total consideration of £32m. Proposed £29m placing at 60p.
For the year ended 31 August 2018, PhD generated revenue of £20.8m and adjusted EBITDA of £2.8m.
“The acquisition of PhD is highly complementary, doubles the size of our business and accelerates our ambition to become a global leader in premium performance nutrition. It is a compelling combination that will deliver a wider product offering, including premium protein, provide broader consumer reach and greater international presence, and dovetails our respective strengths in retail and e-commerce channels.”
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX. If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.